{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:54:27Z","timestamp":1794905667348,"version":"4.9.1"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["311250302"],"award-info":[{"award-number":["311250302"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["Z2024JC005"],"award-info":[{"award-number":["Z2024JC005"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0534"],"award-info":[{"award-number":["2024NSFSC0534"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1604"],"award-info":[{"award-number":["2024NSFSC1604"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3603800"],"award-info":[{"award-number":["2023YFC3603800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3603804"],"award-info":[{"award-number":["2023YFC3603804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92248304"],"award-info":[{"award-number":["92248304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuropharm.2026.111027","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:21:21Z","timestamp":1778944881000},"page":"111027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Progress in precision drug delivery systems for neurodegenerative diseases with muscle atrophy"],"prefix":"10.1016","volume":"297","author":[{"given":"Gongchang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2601-5855","authenticated-orcid":false,"given":"Birong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.neuropharm.2026.111027_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/nu15153456","article-title":"Underlying mechanisms of brain aging and neurodegenerative diseases as potential targets for preventive or therapeutic strategies using phytochemicals","volume":"15","author":"Abdolmaleky","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14678","article-title":"The potential of phosphorylated \u03b1-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy","volume":"30","author":"Abdul-Rahman","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.111027_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111027_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112854","article-title":"Neurodegenerative diseases: from molecular basis to therapy","volume":"23","author":"Agnello","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib5","article-title":"Growth hormone and IGF-1 actions in the brain and neuropsychiatric diseases","author":"Aguiar-Oliveira","year":"2025","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.neuropharm.2026.111027_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-0716-3969-6_15","article-title":"Visualization and quantification of organelle axonal transport in cultured neurons","volume":"2831","author":"Aiken","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jcsm.13485","article-title":"Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia","volume":"15","author":"Amini","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","article-title":"Targeting mitophagy in neurodegenerative diseases","volume":"24","author":"Antico","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu15081853","article-title":"Sarcopenia and cognitive decline in older adults: targeting the muscle-brain axis","volume":"15","author":"Arosio","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2026.111027_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.138098","article-title":"Augmentation of neural stem cell proliferation and enhanced differentiation toward neural and oligodendroglia lineages through sonic hedgehog pathway: cross-activation of Notch1 and SOX10","volume":"848","author":"Azizi","year":"2025","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib11","article-title":"Single-cut gene therapy in a one-step generated rhesus monkey model of Duchenne muscular dystrophy","volume":"6","author":"Bai","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib12","first-page":"2073","article-title":"The physiopathology of brain-derived neurotrophic factor","volume":"105","author":"Barde","year":"2025","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040625","article-title":"Lewy body-like pathology and loss of dopaminergic neurons in midbrain organoids derived from familial Parkinson's disease patient","volume":"12","author":"Becerra-Calixto","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111027_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2024.12.001","article-title":"Procognitive and neurotrophic benefits of \u03b15-GABA-A receptor positive allosteric modulation in a \u03b2-amyloid deposition mouse model of Alzheimer's disease pathology","volume":"147","author":"Bernardo","year":"2025","journal-title":"Neurobiol. Aging"},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2026.111027_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/21678421.2023.2165947","article-title":"Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review","volume":"24","author":"Berry","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111027_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168554","article-title":"Disruption of axonal transport in neurodegeneration","volume":"133","author":"Berth","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.111027_bib17","series-title":"Intranasal Dantrolene Nanoparticles for Treatment of Amyotrophic Lateral Sclerosis as a Disease-Modifying Drug","author":"Bhuiyan","year":"2025"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010415","article-title":"GH\/IGF-1 abnormalities and muscle impairment: from basic research to clinical practice","volume":"22","author":"Biagetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40263-022-00941-1","article-title":"Onasemnogene abeparvovec: a review in spinal muscular atrophy","volume":"36","author":"Blair","year":"2022","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/japplphysiol.00659.2022","article-title":"Early-stage Alzheimer's disease: are skeletal muscle and exercise the key?","volume":"134","author":"Brisendine","year":"2023","journal-title":"J. Appl. Physiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111027_bib21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/acn3.51370","article-title":"Spinocerebellar ataxia clinical trials: opportunities and challenges","volume":"8","author":"Brooker","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/BST20120010","article-title":"Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies","volume":"40","author":"Brunden","year":"2012","journal-title":"Biochem. Soc. Trans."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111027_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116016","article-title":"Protein aggregation landscape in neurodegenerative diseases: clinical relevance and future applications","volume":"22","author":"Candelise","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102739","article-title":"Fluid-based biomarkers for neurodegenerative diseases","volume":"108","author":"Cao","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.111027_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2024.102693","article-title":"Purinergic-associated immune responses in neurodegenerative diseases","volume":"243","author":"Carracedo","year":"2024","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41398-021-01562-w","article-title":"Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms","volume":"11","author":"Cavanagh","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-024-00349-z","article-title":"AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice","volume":"14","author":"Chen","year":"2024","journal-title":"Skeletal Muscle"},{"issue":"50","key":"10.1016\/j.neuropharm.2026.111027_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12967-023-04369-z","article-title":"Mitochondrial dysfunction: roles in skeletal muscle atrophy","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040398","article-title":"Biomarkers for managing neurodegenerative diseases","volume":"14","author":"Cheslow","year":"2024","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib31","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/s41591-025-03890-6","article-title":"A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis","volume":"31","author":"Chia","year":"2025","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00429-020-02044-3","article-title":"Dissociation of somatostatin and parvalbumin interneurons circuit dysfunctions underlying hippocampal theta and gamma oscillations impaired by amyloid \u03b2 oligomers in vivo","volume":"225","author":"Chung","year":"2020","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2026.111027_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251364018","article-title":"Advancing clinical use of neurofilament light chain: translational insights from research to routine practice","volume":"20","author":"Civita","year":"2025","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.neuropharm.2026.111027_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.886243","article-title":"Irisin serum levels and skeletal muscle assessment in a cohort of charcot-marie-tooth patients","volume":"13","author":"Colaianni","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7763","key":"10.1016\/j.neuropharm.2026.111027_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-019-1352-7","article-title":"Whole-animal connectomes of both Caenorhabditis elegans sexes","volume":"571","author":"Cook","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/alz.12450","article-title":"The costs of developing treatments for Alzheimer's disease: a retrospective exploration","volume":"18","author":"Cummings","year":"2022","journal-title":"Alzheimer's Dement."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib37","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E25-01-0005","article-title":"Nerve growth factor signaling tunes axon maintenance protein abundance and kinetics of Wallerian degeneration","volume":"36","author":"Danos","year":"2025","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuropharm.2026.111027_bib38","article-title":"Patient2Trial: from patient to participant in clinical trials using large language models","volume":"53","author":"Datta","year":"2025","journal-title":"Inform. Med. Unlocked"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib39","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111027_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41593-024-01619-1","article-title":"Messenger RNA transport on lysosomal vesicles maintains axonal mitochondrial homeostasis and prevents axonal degeneration","volume":"27","author":"De Pace","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","article-title":"Targeting synapse function and loss for treatment of neurodegenerative diseases","volume":"23","author":"Dejanovic","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16243","article-title":"Cross-species translational paradigms for assessing positive valence system as defined by the RDoC matrix","volume":"169","author":"Dexter","year":"2025","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41583-020-0278-2","article-title":"Presynaptic calcium channels: specialized control of synaptic neurotransmitter release","volume":"21","author":"Dolphin","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111027_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.164","article-title":"Towards IVDR-compliance by implementing quality control steps in a quantitative extracellular vesicle-miRNA liquid biopsy assay for response monitoring in patients with classic hodgkin lymphoma","volume":"3","author":"Drees","year":"2024","journal-title":"J. Extracell. Biol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib45","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.ymthe.2025.06.028","article-title":"Gene therapy with covalently closed-end AAV vector for spinal muscular atrophy","volume":"33","author":"Duan","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111027_bib46","article-title":"Aduhelm: biogen abandons Alzheimer's drug after controversial approval left it unfunded by medicare","volume":"384","author":"Dyer","year":"2024","journal-title":"Br. Med. J."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111027_bib47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.medj.2022.09.007","article-title":"Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis","volume":"3","author":"Edavettal","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.neuropharm.2026.111027_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ymben.2024.12.003","article-title":"Metabolic engineering improves transduction efficiency and downstream vector isolation by altering the lipid composition of extracellular vesicle-enclosed AAV","volume":"88","author":"Espinoza","year":"2025","journal-title":"Metab. Eng."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002607","article-title":"Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease","volume":"22","author":"Eteleeb","year":"2024","journal-title":"PLoS Biol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111027_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70099","article-title":"CRISPR technology in disease management: an updated review of clinical translation and therapeutic potential","volume":"58","author":"Far","year":"2025","journal-title":"Cell Prolif."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111027_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neucli.2018.09.001","article-title":"The utility of motor unit number index: a systematic review","volume":"48","author":"Fatehi","year":"2018","journal-title":"Neurophysiol. Clin."},{"issue":"10360","key":"10.1016\/j.neuropharm.2026.111027_bib52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.111027_bib53","doi-asserted-by":"crossref","unstructured":"Finkel Richard S, Mercuri E, Darras Basil T, Connolly Anne M, Kuntz Nancy L, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med.377(18):1723-1732. https:\/\/doi.org\/10.1056\/NEJMoa1702752.","DOI":"10.1056\/NEJMoa1702752"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111027_bib54","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.18632\/aging.202913","article-title":"Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial","volume":"13","author":"Fitzgerald","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111027_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065914","article-title":"Alpha synuclein: neurodegeneration and inflammation","volume":"24","author":"Forloni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7526","key":"10.1016\/j.neuropharm.2026.111027_bib56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nj7526-299a","article-title":"Neurodegenerative disease: brain windfall","volume":"515","author":"Gammon","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113892","article-title":"Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis","volume":"43","author":"Gao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.111027_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1424025","article-title":"Diving deep: zebrafish models in motor neuron degeneration research","volume":"18","author":"Garg","year":"2024","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1176\/appi.prcp.20200003","article-title":"Shortened positive and negative symptom scale as an alternate clinical endpoint for acute schizophrenia trials: analysis from the US food & drug administration","volume":"3","author":"Gopalakrishnan","year":"2021","journal-title":"Psychiatr. Res. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2026.111027_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105428","article-title":"The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes","volume":"157","author":"Grodstein","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"8070","key":"10.1016\/j.neuropharm.2026.111027_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41586-025-09020-z","article-title":"Programmable control of spatial transcriptome in live cells and neurons","volume":"643","author":"Han","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111027_bib63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol. Cell"},{"issue":"7772","key":"10.1016\/j.neuropharm.2026.111027_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","article-title":"Conserved cell types with divergent features in human versus mouse cortex","volume":"573","author":"Hodge","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2026.111027_bib66","series-title":"Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia","author":"Hsiao-Nakamoto","year":"2024"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70330","article-title":"A novel genetic TDP-43 pig model mimics multiple key ALS-like features","volume":"6","author":"Huang","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.neuropharm.2026.111027_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118526","article-title":"Targeting KCNN4 channels modulates microglial activation and apoptosis in a PD-relevant inflammatory model","volume":"191","author":"Hung","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"47","key":"10.1016\/j.neuropharm.2026.111027_bib69","article-title":"Tissue programmed hydrogels functionalized with GDNF improve human neural grafts in parkinson's disease","volume":"31","author":"Hunt","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111027_bib70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD","volume":"30","author":"Irwin","year":"2024","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111027_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf994","article-title":"Canonical translation factors eIF1A and eIF5B modulate the initiation step of repeat-associated non-AUG translation","volume":"53","author":"Ito","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib72","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/cpt.2544","article-title":"Neurodegenerative diseases: the value of early predictive end points","volume":"111","author":"Janicki Hsieh","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111027_bib73","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2021.07.042","article-title":"Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening","volume":"337","author":"Ji","year":"2021","journal-title":"J. Contr. Release"},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111027_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241613021","article-title":"From pathogenesis to therapeutics: a review of 150 years of huntington's disease research","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111027_bib74","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1016\/j.molcel.2021.07.038","article-title":"Interaction of tau with HNRNPA2B1 and N(6)-methyladenosine RNA mediates the progression of tauopathy","volume":"81","author":"Jiang","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib76","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12915-023-01751-7","article-title":"A systematic review of the development and application of home cage monitoring in laboratory mice and rats","volume":"21","author":"Kahnau","year":"2023","journal-title":"BMC Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111027_bib77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41583-024-00806-0","article-title":"Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases","volume":"25","author":"Kampmann","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111027_bib78","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1039\/D3LC00124E","article-title":"Manufactured tissue-to-tissue barrier chip for modeling the human blood-brain barrier and regulation of cellular trafficking","volume":"23","author":"Kim","year":"2023","journal-title":"Lab Chip"},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111027_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25169073","article-title":"Oxysterol induces expression of 60 kDa chaperone protein on cell surface of microglia","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111027_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169295","article-title":"ATP as a key modulator of fused-in-sarcoma phase separation and aggregation: insights into amyotrophic lateral sclerosis pathogenesis","volume":"437","author":"Kitamura","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111027_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mad.2016.10.001","article-title":"Mouse models of ageing and their relevance to disease","volume":"160","author":"K\u00f5ks","year":"2016","journal-title":"Mech. Ageing Dev."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111027_bib82","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","article-title":"O-GlcNAcylation in health and neurodegenerative diseases","volume":"53","author":"Lee","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111027_bib83","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41593-021-00944-z","article-title":"Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS","volume":"24","author":"Lee","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib84","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13770-025-00703-2","article-title":"Mesenchymal stem cells expressing baculovirus-engineered brain-derived neurotrophic factor improve peripheral nerve regeneration in a rat model","volume":"22","author":"Lee","year":"2025","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.neuropharm.2026.111027_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2020.586453","article-title":"Histone deacetylase 6 and the disease mechanisms of \u03b1-Synucleinopathies","volume":"12","author":"Lemos","year":"2020","journal-title":"Front. Synaptic Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.scr.2016.06.003","article-title":"Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases","volume":"17","author":"Lenzi","year":"2016","journal-title":"Stem Cell Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib88","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13023-025-03857-3","article-title":"Epigenetic regulation in spinal muscular atrophy: emerging areas and future directions","volume":"20","author":"Li","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib87","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41593-023-01374-9","article-title":"Globally reduced N(6)-methyladenosine (m(6)A) in C9ORF72-ALS\/FTD dysregulates RNA metabolism and contributes to neurodegeneration","volume":"26","author":"Li","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106350","article-title":"Epothilone B inactivation of Sirtuin1 promotes mitochondrial reactive oxygen species to induce dysfunction and ferroptosis of schwann cells","volume":"181","author":"Liang","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib90","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41380-021-01394-6","article-title":"Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism","volume":"27","author":"Lindholm","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111027_bib91","article-title":"Electroacupuncture attenuates inflammation after ischemic stroke by inhibiting NF-\u03baB-Mediated activation of microglia","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.neuropharm.2026.111027_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101763","article-title":"Mesencephalic astrocyte-derived neurotrophic factor (MANF): structure, functions and therapeutic potential","volume":"82","author":"Liu","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111027_bib93","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000525639","article-title":"Descriptive epidemiology of neurodegenerative diseases: what are the critical questions?","volume":"56","author":"Logroscino","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"9630","key":"10.1016\/j.neuropharm.2026.111027_bib94","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.111027_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2023.102394","article-title":"Spinal and bulbar muscular atrophy: from molecular pathogenesis to pharmacological intervention targeting skeletal muscle","volume":"71","author":"Marchioretti","year":"2023","journal-title":"Curr. Opin. Pharmacol."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111027_bib96","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited alzheimer disease","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"issue":"8049","key":"10.1016\/j.neuropharm.2026.111027_bib97","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41586-024-08462-1","article-title":"Rapid and scalable personalized ASO screening in patient-derived organoids","volume":"638","author":"Means","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111027_bib98","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1021\/acsptsci.5c00162","article-title":"Modernizing preclinical drug development: the role of new approach methodologies","volume":"8","author":"Mehta","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031697","article-title":"Hereditary spastic paraplegia: an update","volume":"23","author":"Meyyazhagan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111027_bib101","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1212\/WNL.0000000000012853","article-title":"CSF synaptic biomarkers in the preclinical stage of alzheimer disease and their association with MRI and PET: a cross-sectional study","volume":"97","author":"Mil\u00e0-Alom\u00e0","year":"2021","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111027_bib103","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.cell.2024.08.024","article-title":"Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function","volume":"187","author":"Miller","year":"2024","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111027_bib102","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2026.111027_bib104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.reth.2019.07.002","article-title":"Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I\/IIa clinical trial (ROPALS trial)","volume":"11","author":"Morimoto","year":"2019","journal-title":"Regen. Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111027_bib105","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib106","article-title":"From bench to brain: translating EV and nanocarrier research into parkinson's disease therapies","volume":"14","author":"Muttiah","year":"2025","journal-title":"Biology (Basel)"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111027_bib107","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jbiosc.2025.05.003","article-title":"Construction of contractile human iPSC-derived skeletal muscle tissues on 96-well scale microdevices","volume":"140","author":"Nakamura","year":"2025","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.neuropharm.2026.111027_bib108","article-title":"Engineering biomimetic tissue barrier models on chips: from design and fabrication to applications in disease modeling and drug screening","volume":"327","author":"Nasiri","year":"2025","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111027_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26189245","article-title":"Pathological calcium signaling in traumatic brain injury and Alzheimer's disease: from acute neuronal injury to chronic neurodegeneration","volume":"26","author":"Neuschmid","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111027_bib110","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","article-title":"Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases","volume":"25","author":"Nixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib111","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12790","article-title":"Relationship of serum beta-synuclein with blood biomarkers and brain atrophy","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimer's Dement."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib112","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/1567205014666170317113159","article-title":"Abnormal clock gene expression and locomotor activity rhythms in two month-old female APPSwe\/PS1dE9 mice","volume":"14","author":"Oyegbami","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2026.111027_bib113","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2022.01.028","article-title":"Neuron-derived neurotrophic factor protects against dexamethasone-induced skeletal muscle atrophy","volume":"593","author":"Ozaki","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2026.111027_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2025.10.005","article-title":"Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson's disease","author":"Padhi","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","article-title":"Autophagy, aging, and age-related neurodegeneration","volume":"113","author":"Palmer","year":"2025","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib116","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111027_bib117","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/bph.15802","article-title":"Altered blood-brain barrier and blood-spinal cord barrier dynamics in amyotrophic lateral sclerosis: impact on medication efficacy and safety","volume":"179","author":"Pan","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib118","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41467-020-20440-5","article-title":"A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids","volume":"12","author":"Park","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib119","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s12864-021-08009-y","article-title":"Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease","volume":"22","author":"Paul","year":"2021","journal-title":"BMC Genom."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib120","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1007\/s10072-023-06867-w","article-title":"An SPG7 mutation as a novel cause of monogenic progressive muscular atrophy","volume":"44","author":"Pereira","year":"2023","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111027_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061660","article-title":"Chitosan-based thermogelling system for nose-to-brain donepezil delivery: optimising formulation properties and nasal deposition profile","volume":"15","author":"Perku\u0161i\u0107","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib123","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111027_bib121","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/ddy397","article-title":"Human SPG11 cerebral organoids reveal cortical neurogenesis impairment","volume":"28","author":"P\u00e9rez-Brangul\u00ed","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111027_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.914017","article-title":"Identification of therapeutic targets for amyotrophic lateral sclerosis using PandaOmics - an AI-Enabled biological target discovery platform","volume":"14","author":"Pun","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib125","article-title":"Changes of sonic hedgehog mediated FAK\/ERK pathway proteins in amyotrophic lateral sclerosis model mice","author":"Qi","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111027_bib126","article-title":"Changes of sonic hedgehog mediated FAK\/ERK pathway proteins in amyotrophic lateral sclerosis model mice","author":"Qi","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib127","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/hum.2010.003","article-title":"Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle","volume":"21","author":"Qiao","year":"2010","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib128","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4103\/NRR.NRR-D-23-01666","article-title":"Reduced mesencephalic astrocyte-derived neurotrophic factor expression by mutant androgen receptor contributes to neurodegeneration in a model of spinal and bulbar muscular atrophy pathology","volume":"20","author":"Qin","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100130","article-title":"Lab-in-the-loop machine learning for brain-targeting delivery system design","volume":"1","author":"Qiu","year":"2025","journal-title":"Cell Biomater."},{"key":"10.1016\/j.neuropharm.2026.111027_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102776","article-title":"Artificial intelligence for drug discovery and development in Alzheimer's disease","volume":"85","author":"Qiu","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib131","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1080\/15548627.2024.2373676","article-title":"Key considerations for investigating and interpreting autophagy in skeletal muscle","volume":"20","author":"Rahman","year":"2024","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib132","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","article-title":"\u03b1-Synuclein aggregation nucleates through liquid-liquid phase separation","volume":"12","author":"Ray","year":"2020","journal-title":"Nat. Chem."},{"issue":"7943","key":"10.1016\/j.neuropharm.2026.111027_bib133","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/d41586-023-00030-3","article-title":"FDA approves Alzheimer's drug lecanemab amid safety concerns","volume":"613","author":"Reardon","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111027_bib134","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/s41592-023-02080-x","article-title":"In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain-striatum-cortex assembloids","volume":"20","author":"Reumann","year":"2023","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25278","article-title":"A phenotypically robust model of spinal and bulbar muscular atrophy in drosophila","volume":"102","author":"Richardson","year":"2024","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib136","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00401-024-02753-7","article-title":"Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies","volume":"147","author":"Robinson","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib137","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00210-021-02096-0","article-title":"Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer's disease","volume":"394","author":"Rompicherla","year":"2021","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"6232","key":"10.1016\/j.neuropharm.2026.111027_bib138","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1126\/science.aaa2958","article-title":"Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injury","volume":"348","author":"Ruschel","year":"2015","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111027_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/cells14161253","article-title":"Calpain in traumatic brain injury: from cinderella to central player","volume":"14","author":"Schallerer","year":"2025","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.neuropharm.2026.111027_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228637","article-title":"Efficacy of sulforaphane in neurodegenerative diseases","volume":"21","author":"Schepici","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog. Neurobiol."},{"issue":"6753","key":"10.1016\/j.neuropharm.2026.111027_bib142","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx0043","article-title":"Neuroinflammation across neurological diseases","volume":"388","author":"Shi","year":"2025","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111027_bib143","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson's progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib144","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10974-025-09700-3","article-title":"The impact of mitokine MOTS-c administration on the soleus muscle of rats subjected to a 7-day hindlimb suspension","volume":"46","author":"Sidorenko","year":"2025","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.neuropharm.2026.111027_bib145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcis.2022.07.025","article-title":"Transport of cationic liposomes in a human blood brain barrier model: role of the stereochemistry of the gemini amphiphile on liposome biological features","volume":"627","author":"Simonis","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102321","article-title":"Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases","volume":"98","author":"Singh","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111027_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168726","article-title":"Cyanobacteria, cyanotoxins, and neurodegenerative diseases: dangerous liaisons","volume":"22","author":"Sini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111027_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083516","article-title":"Biomarkers of skeletal muscle atrophy based on atrogenes evaluation: a systematic review and meta-analysis study","volume":"26","author":"Souza","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010136","article-title":"How to build and to protect the neuromuscular junction: the role of the glial cell line-derived neurotrophic factor","volume":"22","author":"Stanga","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib151","series-title":"Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices: 1940-087X","author":"Stoklund Dittlau","year":"2021"},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111027_bib152","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1212\/WNL.0000000000200898","article-title":"Association of pace of aging measured by blood-based DNA methylation with age-related cognitive impairment and dementia","volume":"99","author":"Sugden","year":"2022","journal-title":"Neurology"},{"issue":"6708","key":"10.1016\/j.neuropharm.2026.111027_bib154","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2992","article-title":"Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming","volume":"385","author":"Sun","year":"2024","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib153","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","article-title":"Gene-based therapies for neurodegenerative diseases","volume":"24","author":"Sun","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111027_bib155","doi-asserted-by":"crossref","first-page":"9876","DOI":"10.1073\/pnas.2002110117","article-title":"Cryo-EM structure of C9ORF72\u2013SMCR8\u2013WDR41 reveals the role as a GAP for Rab8a and Rab11a","volume":"117","author":"Tang","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111027_bib156","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","article-title":"Advancing cell therapy for neurodegenerative diseases","volume":"30","author":"Temple","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib157","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"issue":"818","key":"10.1016\/j.neuropharm.2026.111027_bib158","article-title":"SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis","volume":"17","author":"Ullrich","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111027_bib159","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1212\/WNL.0000000000009818","article-title":"In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment","volume":"95","author":"Vanhaute","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111027_bib160","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","article-title":"Neuromuscular junction dysfunction in amyotrophic lateral sclerosis","volume":"59","author":"Verma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111027_bib164","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jare.2024.02.013","article-title":"MCU complex: exploring emerging targets and mechanisms of mitochondrial physiology and pathology","volume":"68","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neuropharm.2026.111027_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102452","article-title":"Friend or foe: lactate in neurodegenerative diseases","volume":"101","author":"Wang","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.111027_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102035","article-title":"Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases","volume":"91","author":"Wang","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111027_bib161","first-page":"1483","article-title":"Advances in genetics research in the pathogenesis of amyotrophic lateral sclerosis","volume":"45","author":"Wang","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010131","article-title":"Lipids as emerging biomarkers in neurodegenerative diseases","volume":"25","author":"Wei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111027_bib166","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2018.06.013","article-title":"\u03b1-Methyl-\u03b1-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy","volume":"118","author":"Wong","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010443","article-title":"Towards understanding neurodegenerative diseases: insights from Caenorhabditis elegans","volume":"25","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib169","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/jnc.16127","article-title":"Antibody engagement with amyloid-beta does not inhibit [11C]PiB binding for PET imaging","volume":"168","author":"Xiong","year":"2024","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111027_bib168","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202401145","article-title":"Presynaptic perspective: axonal transport defects in neurodevelopmental disorders","volume":"223","author":"Xiong","year":"2024","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111027_bib170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2022.01.030","article-title":"Activation of autophagy attenuates motor deficits and extends lifespan in a C. elegans model of ALS","volume":"181","author":"Xu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.111027_bib174","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jconrel.2023.11.057","article-title":"Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications","volume":"365","author":"Yang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib171","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jcsm.13123","article-title":"\u03b1-Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration","volume":"14","author":"Yang","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"97","key":"10.1016\/j.neuropharm.2026.111027_bib173","doi-asserted-by":"crossref","first-page":"eadm7908","DOI":"10.1126\/sciimmunol.adm7908","article-title":"Infection and chronic disease activate a systemic brain-muscle signaling axis","volume":"9","author":"Yang","year":"2024","journal-title":"Sci. Immunol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111027_bib172","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jnnp-2022-330931","article-title":"Epigenetic clocks in neurodegenerative diseases: a systematic review","volume":"94","author":"Yang","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111027_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.977617","article-title":"Extracellular vesicle-derived miRNAs improve stem cell-based therapeutic approaches in muscle wasting conditions","volume":"13","author":"Yedigaryan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111027_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105807","article-title":"Skeletal muscle atrophy: from mechanisms to treatments","volume":"172","author":"Yin","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib177","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s13238-022-00912-8","article-title":"New pathogenic insights from large animal models of neurodegenerative diseases","volume":"13","author":"Yin","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.neuropharm.2026.111027_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105119","article-title":"Development of cross-species translational paradigms for psychiatric research in the research domain criteria era","volume":"148","author":"Young","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib179","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12951-025-03572-y","article-title":"Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier","volume":"23","author":"Yuan","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111027_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094951","article-title":"Role of bioactives in neurodegenerative diseases","volume":"25","author":"Zacharia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111027_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/mef2.70008","article-title":"The recent development, application, and future prospects of muscle atrophy animal models","volume":"3","author":"Zhang","year":"2024","journal-title":"MedComm \u2013 Future Med."},{"key":"10.1016\/j.neuropharm.2026.111027_bib182","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2146167","article-title":"Traditional acupuncture meets modern nanotechnology: opportunities and perspectives","volume":"2019","author":"Zhang","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib186","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s42003-025-08839-6","article-title":"Interaction of the mitochondrial calcium\/proton exchanger TMBIM5 with MICU1","volume":"8","author":"Zhang","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib183","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10571-024-01486-1","article-title":"Application of optogenetics in neurodegenerative diseases","volume":"44","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib184","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-024-00429-6","article-title":"Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib187","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111027_bib188","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202501007","article-title":"SOD1 is delivered to lysosomes via autophagy to maintain lysosomal function and integrity","volume":"224","author":"Zheng","year":"2025","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111027_bib189","article-title":"Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database","volume":"15","author":"Zheng","year":"2025","journal-title":"Sci. Rep."},{"issue":"51","key":"10.1016\/j.neuropharm.2026.111027_bib191","article-title":"Fluorescent diagnostic probes in neurodegenerative diseases","volume":"32","author":"Zhou","year":"2020","journal-title":"Adv. Mater."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111027_bib190","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1021\/acs.jmedchem.9b00672","article-title":"Environment-sensitive near-infrared probe for fluorescent discrimination of A\u03b2 and tau fibrils in AD brain","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:49:54Z","timestamp":1783169394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":191,"alternative-id":["S0028390826002005"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111027","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in precision drug delivery systems for neurodegenerative diseases with muscle atrophy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111027"}}